Retatrutide keeps helping people lose weight steadily for a whole year without slowing down, while other weight-loss drugs like GLP-1s tend to stop working as well after a few months.
Evidence from Studies
Supporting (0)
Community contributions welcome
Contradicting (2)
Community contributions welcome
Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials
The study shows retatrutide helps people lose weight, but it doesn’t show how the weight loss happens over time or whether it keeps dropping without leveling off, so we can’t say if it’s different from other drugs in that way.
The study shows retatrutide helps people lose a lot of weight, but it doesn’t say whether the weight loss keeps going down steadily or levels off over time, so we can’t tell if it’s different from other drugs in that way.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.